Edward F. Smith III serves as Executive at Conatus Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Edward F. Smith III has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 14, 2018 involved receiving (via award) 1,724 shares valued at $5.4K.
Edward F. Smith III currently holds 10,875 shares of Conatus Pharmaceuticals Inc. (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward F. Smith III has been a net neutral trader of CNAT stock. They have purchased $0 and sold $0 worth of shares.
Edward F. Smith III's most recent insider trade was on Nov 14, 2018, when they sold 1,724 shares at $3.15 per share.
Get notified when new Form 4 filings are submitted
| $3.31 |
| Discretionary |
| Nov 14, 2017 | CNAT | $15.5K | Award | 4,461 | $3.48 | Discretionary |